C
NVAX icon

Covestor’s Novavax NVAX Stock Holding History

Covestor’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8K Buy
866
+41
+5% +$367 ﹤0.01% 1734
2026
Q1 		$7K Sell
825
-671
-45% -$6.08K ﹤0.01% 1676
2025
Q4 		$10K Sell
1,496
-1
-0.1% -$8 0.01% 1585
2025
Q3 		$13K Sell
1,497
-2
-0.1% -$16 0.01% 1469
2025
Q2 		$9K Buy
1,499
+860
+135% +$5.69K 0.01% 1643
2025
Q1 		$4K Buy
639
+3
+0.5% +$25 ﹤0.01% 1757
2024
Q4 		$5K Buy
636
+1
+0.2% +$10 ﹤0.01% 1729
2024
Q3 		$8K Sell
635
-1,241
-66% -$16K 0.01% 1665
2024
Q2 		$24K Buy
1,876
+7
+0.4% +$70 0.02% 1140
2024
Q1 		$9K Buy
1,869
+964
+107% +$4.47K 0.01% 1659
2023
Q4 		$4K Hold
905
– – ﹤0.01% 1783
2023
Q3 		$7K Buy
905
+3
+0.3% +$24 0.01% 1633
2023
Q2 		$7K Buy
902
+484
+116% +$3.81K 0.01% 1636
2023
Q1 		$3K Hold
418
– – ﹤0.01% 1693
2022
Q4 		$4K Buy
418
+210
+101% +$3.71K ﹤0.01% 1634
2022
Q3 		$4K Sell
208
-1
-0.5% -$43 ﹤0.01% 1566
2022
Q2 		$11K Buy
209
+115
+122% +$5.96K 0.01% 1182
2022
Q1 		$7K Buy
94
+40
+74% +$3.57K ﹤0.01% 1416
2021
Q4 		$8K Buy
+54
New +$9.28K 0.01% 1108

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Covestor's NVAX Position: Q2 2026 in Review

Covestor increased its Novavax (NVAX) stake by 5% in Q2 2026, buying an estimated $367 and bringing the position to 866 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1734.

Covestor first reported a position in NVAX in Q4 2021 and has held it in 19 quarters since. The position peaked at $24K in Q2 2024. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Covestor held 866 shares of Novavax worth $8K as of Q2 2026.
  • Covestor bought 41 Novavax shares in Q2 2026, an estimated $367.
  • Novavax made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #1734 holding.
  • Covestor first reported a position in Novavax in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Novavax position peaked at $24K in Q2 2024.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.